People · Operator
Named in public records as an officer, director or promoter · active 2011–2020 · Other Technology, Other Health Care
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| T2 Biosystems, Inc. | — | Other Technology | Series D+ | $477.6M | $1.3B | 2011 |
| Carrot Inc. | — | Other Health Care | Series B | $51.0M | $20.8M | 2018 |
Stacy Feld at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Stacy Feld on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Robert Langer | 1 | 36 |
| Samir Kaul | 1 | 32 |
| Michael Greeley | 1 | 15 |
| Alan Crane | 1 | 9 |
| Harry Wilcox | 1 | 6 |
| John McDonough | 1 | 5 |
| Adrian M. Jones | 1 | 5 |
| Michael Cima | 1 | 4 |
| ASHA NAYAK | 1 | 3 |
| Ryan Phillips | 1 | 3 |
| Jack Stoddard | 1 | 2 |
| John W. Cumming | 1 | 2 |
| Thomas Lowery | 1 | 2 |
| David Utley | 1 | 2 |
| DOUG LEVINSON | 1 | 2 |
| Stanley M. Lapidus | 1 | 1 |
| Josh A. Bilenker, M.D. | 1 | 1 |
| Elizabeth Burr | 1 | 1 |
| Jeffrey Wiesen | 1 | 1 |
| Stan Lapidus | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.